Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 10, 2018; 90 (15 Supplement) April 23, 2018

Autonomic description in patients with very early TTR amyloidosis (Familial Amyloid Polyneuropathy). (P2.115)

Maria Alejandra Gonzalez Duarte, Carlo Enrico Bañuelos, Karen García, Omar Fueyo, Carolina Dominguez, Karla Cardenas-Soto
First published April 9, 2018,
Maria Alejandra Gonzalez Duarte
1Instituto Nacional De Sciencias Medicas Mexico City Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlo Enrico Bañuelos
2Instituto Nacional de Ciencias Médicas y Nutrición CDMX Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen García
2Instituto Nacional de Ciencias Médicas y Nutrición CDMX Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omar Fueyo
2Instituto Nacional de Ciencias Médicas y Nutrición CDMX Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina Dominguez
2Instituto Nacional de Ciencias Médicas y Nutrición CDMX Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karla Cardenas-Soto
2Instituto Nacional de Ciencias Médicas y Nutrición CDMX Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Autonomic description in patients with very early TTR amyloidosis (Familial Amyloid Polyneuropathy). (P2.115)
Maria Alejandra Gonzalez Duarte, Carlo Enrico Bañuelos, Karen García, Omar Fueyo, Carolina Dominguez, Karla Cardenas-Soto
Neurology Apr 2018, 90 (15 Supplement) P2.115;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To describe autonomic dysfunction between different methods of assessment in patients with ATTR at an early stage of the disease.

Background: Autonomic dysfunction is infrequently considered or limited to orthostatic hypotension or erectile dysfunction. These is insufficient to warrant treatment for life, and more objective measurements should be regarded.

Design/Methods: Thirty-three patients were selected from a cohort of patients with TTR amyloidosis that fulfilled the diagnostic criteria: a positive amyloid mutation, stage 0 or I in Coutinho’s classification, and abnormal neurophysiologic or cardiologic tests that would show initiation of the disease. All patients completed all the clinical and autonomic evaluations.

Results: Peripheral Neuropathy: Mean NIS was 6.9±12.8 points (0–61), mean UTAH Scale was 4.5±5.2 points (0–18), and mean Neuropathic score NTSS-6 was 3.9±5.4 points (health care professional) and 15.2±5.5 (self-administated). HRDB: All patients were below the 5th percentil for their age with HR response to DB. Mean E:I ratio was significantly more impaired in patients older than 40yo (24 vs 7 beats, p=0.001). Valsalva Ratio: VR was abnormal in 42% of patients above 40 years old. Tilt Test: SBP drop was higher in the tilt test than the standing up test with a mean drop of the SBP 74±17.7mmHg (100–27mmHg) with a maximum HR at minimum SBP significantly lower in patients older than 40 years old (125.9 vs 74 beats), p=0.000). 24-h BP recording: Mean SBP change was −84±26.6mmHg(−139—36mmHg), and DBP change was −83±31.9mmHg (−172-0). Spectral Analysis of HRV: Statistical difference was found between older than 40 years old and younger in SDNN (19.2±9.4 vs 56.6±31.1, P=0.003), TINN (230.99±126.7 vs 571.62±284.8, P=0.006), rMSSD (7±9.53 vs 24±34, P=0.42).

Conclusions: Even at a very early stage of somatic neuropathy the patients showed important alterations in all autonomic tests.

Disclosure: Dr. Gonzalez Duarte has nothing to disclose. Dr. Bañuelos has nothing to disclose. Dr. García has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Pfizer and Anhylam pharmaceuticals. Dr. García has received research support from Pfizer. Dr. Fueyo has nothing to disclose. Dr. Dominguez has nothing to disclose. Dr. Cardenas-Soto has nothing to disclose.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 98 (24)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise